(8S)-13-(6-CHLORO-5-CYCLOPROPYL-1H-INDAZOL-4-YL)-14-FLUORO-17-(((8S)-6-METHYLIDENE-2,3,5,7-TETRAHYDRO-1H-PYRROLIZIN-8-YL)METHOXY)-6,10-DIOXA-2,12,16,18-TETRAZATETRACYCLO(9.7.1.02,8.015,19)NONADECA-1(18),11,13,15(19),16-PENTAENE
UNII 786G7X77DW
Substance Identification & Data
This profile provides standardized clinical and technical data for (8s)-13-(6-chloro-5-cyclopropyl-1h-indazol-4-yl)-14-fluoro-17-(((8s)-6-methylidene-2,3,5,7-tetrahydro-1h-pyrrolizin-8-yl)methoxy)-6,10-dioxa-2,12,16,18-tetrazatetracyclo(9.7.1.02,8.015,19)nonadeca-1(18),11,13,15(19),16-pentaene, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 786G7X77DW.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3058573-95-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C32H33ClFN7O3 DXOMOBYVTNQMSC-GTJUCTONSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (8s)-13-(6-chloro-5-cyclopropyl-1h-indazol-4-yl)-14-fluoro-17-(((8s)-6-methylidene-2,3,5,7-tetrahydro-1h-pyrrolizin-8-yl)methoxy)-6,10-dioxa-2,12,16,18-tetrazatetracyclo(9.7.1.02,8.015,19)nonadeca-1(18),11,13,15(19),16-pentaene. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.